×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRXP – nrx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/2
08:03 am
nrxp
Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics
High
Report
Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics
12/31
08:22 am
nrxp
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
High
Report
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
12/30
08:11 am
nrxp
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression [Yahoo! Finance]
Low
Report
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression [Yahoo! Finance]
12/30
08:03 am
nrxp
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression
Medium
Report
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression
12/2
08:06 am
nrxp
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) had its price target raised by analysts at Ascendiant Capital Markets from $44.00 to $45.00. They now have a "buy" rating on the stock.
Medium
Report
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) had its price target raised by analysts at Ascendiant Capital Markets from $44.00 to $45.00. They now have a "buy" rating on the stock.
11/27
01:17 pm
nrxp
NRx Pharmaceuticals (NRXP) Upgraded to Buy: Here's Why [Yahoo! Finance]
Low
Report
NRx Pharmaceuticals (NRXP) Upgraded to Buy: Here's Why [Yahoo! Finance]
11/26
08:16 am
nrxp
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024 [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024 [Yahoo! Finance]
11/26
08:03 am
nrxp
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024
Medium
Report
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2024
04:01 pm
nrxp
nrx pharmaceuticals, inc.
BEAT
Report
2.6%
nrx pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
12/18
08:28 am
nrxp
Form 4 NRX Pharmaceuticals, For: Dec 17 Filed by: Javitt Jonathan C
High
Report
Form 4 NRX Pharmaceuticals, For: Dec 17 Filed by: Javitt Jonathan C
11/22
01:44 pm
nrxp
Form 3 NRX Pharmaceuticals, For: Nov 18 Filed by: ABRAMS MICHAEL S
Low
Report
Form 3 NRX Pharmaceuticals, For: Nov 18 Filed by: ABRAMS MICHAEL S
11/20
09:01 am
nrxp
Form 8-K NRX Pharmaceuticals, For: Nov 18
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Nov 18
11/15
05:24 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Nov 14
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Nov 14
11/14
04:03 pm
nrxp
Form 10-Q NRX Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q NRX Pharmaceuticals, For: Sep 30
10/31
08:00 am
nrxp
Form 8-K NRX Pharmaceuticals, For: Oct 30
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Oct 30
10/15
04:52 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Oct 10
Low
Report
Form 8-K NRX Pharmaceuticals, For: Oct 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: